Source link : https://newshealth.biz/health-news/myasthenia-gravis-drug-shows-benefits-in-wider-range-of-patients/
(MedPage Today) — SAN FRANCISCO — Intravenous efgartigimod (Vyvgart) met its primary endpoint in adults with acetylcholine receptor (AChR) antibody-negative myasthenia gravis, the ADAPT SERON trial showed. At week 4, Myasthenia Gravis Activities… Source link : https://www.medpagetoday.com/meetingcoverage/aanem/118255 Author : Publish date : 2025-10-31 15:11:00 Copyright for syndicated content belongs to the linked Source.
The post Myasthenia Gravis Drug Shows Benefits in Wider Range of Patients first appeared on News Health.
—-
Author : News Health
Publish date : 2025-10-31 15:11:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8